All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. Towards a better managed off-label use of drugs

    KCE Reports 252 (2015)

    https://kce.fgov.be/en/towards-a-better-managed-off-label-use-of-drugs

  2. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study

  3. The long-term efficacy of psychotherapy, alone or in combination with antidepressants, in the treatment of adult major depression

    KCE Reports 230 (2014)

    https://kce.fgov.be/en/the-long-term-efficacy-of-psychotherapy-alone-or-in-combination-with-antidepressants-in-the

  4. Supportive treatment for cancer – Part 3: Treatment of pain: most common practices

    KCE Reports 211 (2013)

    https://kce.fgov.be/en/supportive-treatment-for-cancer-%E2%80%93-part-3-treatment-of-pain-most-common-practices

  5. Barriers and opportunities for the uptake of biosimilar medicines in Belgium

    KCE Reports 199 (2013)

    https://kce.fgov.be/en/barriers-and-opportunities-for-the-uptake-of-biosimilar-medicines-in-belgium

  6. Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy

    KCE Reports 191 (2012)

    https://kce.fgov.be/en/supportive-treatment-for-cancer-part-2-prevention-and-treatment-of-adverse-events-related-to

  7. [Vaccine safety surveillance in Belgium : place and limits of a background rate approach]

    KCE Reports 188 (2012)

    https://kce.fgov.be/en/vaccine-safety-surveillance-in-belgium-place-and-limits-of-a-background-rate-approach

  8. [Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]

    KCE Reports 157 (2011)

    https://kce.fgov.be/en/economic-evaluation-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium

  9. Pharmacological prevention of fragility fractures in Belgium

    KCE Reports 159 (2011)

    https://kce.fgov.be/en/pharmacological-prevention-of-fragility-fractures-in-belgium

  10. [Statins in Belgium: utilization trends and impact of reimbursement policies]

    KCE Reports 141 (2010)

    https://kce.fgov.be/en/statins-in-belgium-utilization-trends-and-impact-of-reimbursement-policies

  11. Seamless care with regard to medications between hospital and home

    KCE Reports 131 (2010)

    https://kce.fgov.be/en/seamless-care-with-regard-to-medications-between-hospital-and-home

  12. Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study

    KCE Reports 127 (2010)

    https://kce.fgov.be/en/cost-effectiveness-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium-part-1-literature-review

  13. Pharmaceutical and non-pharmaceutical interventions for Alzheimer’s Disease, a rapid assessment

    KCE Reports 111 (2009)

    https://kce.fgov.be/en/pharmaceutical-and-non-pharmaceutical-interventions-for-alzheimer%E2%80%99s-disease-a-rapid-assessment

  14. Tiotropium in the Treatment of Chronic Obstructive Pulmonary Disease: Health Technology Assessment

    KCE Reports 108 (2009)

    https://kce.fgov.be/en/tiotropium-in-the-treatment-of-chronic-obstructive-pulmonary-disease-health-technology-assessment

  15. Antiviral agents in seasonal and pandemic influenza. Literature study and development of practice guidelines

    KCE Reports 49 (2006)

    https://kce.fgov.be/en/antiviral-agents-in-seasonal-and-pandemic-influenza-literature-study-and-development-of-practice

  16. Medication use in rest and nursing homes in Belgium.

    KCE Reports 47 (2006)

    https://kce.fgov.be/en/medication-use-in-rest-and-nursing-homes-in-belgium

  17. Pharmacological and surgical treatment of obesity. Residential care for severely obese children in Belgium.

    KCE Reports 36 (2006) August 2006 (3rd edition ; 2nd edition : July 2006 ; 1st edition : June 2006)

    https://kce.fgov.be/en/pharmacological-and-surgical-treatment-of-obesity-residential-care-for-severely-obese-children-in

  18. Trastuzumab in Early Stage Breast Cancer

    KCE Reports 34 (2006) 30 June (2nd edition; 22 June 2006, 1st edition)

    https://kce.fgov.be/en/trastuzumab-in-early-stage-breast-cancer

  19. [Antibiotics use in hospitals for acute pyelonephritis]

    KCE Reports 3 (2004)

    https://kce.fgov.be/en/antibiotics-use-in-hospitals-for-acute-pyelonephritis

  20. [Effectiveness and cost-effectiveness of treatments for smoking cessation]

    KCE Reports 1 (2004) 22 juillet 2004 (1st print), août 2005 (2nd print)

    https://kce.fgov.be/en/effectiveness-and-cost-effectiveness-of-treatments-for-smoking-cessation

Pages